Found 40 matching trials
An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment N/A In this observational study, participants receive darolutamide: a treatment...
Show More Learn More & Join Trial
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice N/A This is an international, prospective, open-label, multicenter, multi-cohor...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients PHASE3 The purpose of this clinical phase 3 randomized trial is to compare two dif...
Show More Status
Active Not Recruiting
Location
Ordensklinikum Linz GmbH, Elisabethinen
Learn More & Join Trial
Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer PHASE2 Researchers are seeking better ways to treat men who have non-metastatic ca...
Show More Learn More & Join Trial
A Study to Learn More About How Safe Darolutamide is Under Real-world Conditions in Participants With Metastatic Hormone-Sensitive Prostate Cancer N/A This is an observational study in which only data are collected from partic...
Show More Status
Active Not Recruiting
Learn More & Join Trial
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable) PHASE3 This is a Phase III, international, multicentre, randomised, double-blinded...
Show More Location
Grand Hopital de Charleroi - site Notre Dame
Learn More & Join Trial
START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC NA Phase III study of stereotactic body radiation therapy (SBRT) plus standard...
Show More Location
Hospital Universitario Ramón y Cajal
Learn More & Join Trial
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response PHASE2 The objective of this study is to determine the safety and clinical effects...
Show More Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer PHASE3 Evaluation of the impact of metastasis-directed therapy in patients with ca...
Show More Location
University Hospitals Leuven
Learn More & Join Trial
Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer PHASE3 The goal of this phase 3 clinical trial is to determine the clinical effect...
Show More Location
Multiple Locations
Learn More & Join Trial